All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) · National trade organization representing the interests of generic drug manufacturers.

Filing 4th Quarter - Termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 5

WILLIAM STEVE SOUTHERLAND II Former member of Congress

Previously held: William Steve Southerland, II served as the U.S. Representative for Florida's 2nd congressional district from2011 to 2015.
BRIAN SUTTER

Previously held: Staff Dir. W&M Health subcommittee, Chairman Dave CampApril'13-Dec'14. Professional Staff, W&M Healthsubcommittee, Chairman Dave Camp, Jan'11-April'13. LegDir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep DaveCamp, Feb'03-May'08. Staff Ast July'02
CHRISTOPHER DAVIS New on this filing

Previously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher(2006-2011).
EMILY ELIZABETH WILKINSON-HOLLAND New on this filing

Previously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen. Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept. of HHS (3/2017-8/2017),Sr Advisor to Administrator - Ctrs for Medicare & Medicaid(8/17- 5/19)
KIMBERLEE TRZECIAK

Previously held: FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

S 43
Skinny Labels, Big Savings Act

Lobbying activity 4

Trade (domestic/foreign)

Issues related to potential tariffs on generic drugs.

Issues S. 43, Skinny Labels, Big Savings Act.

Health Issues

- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act. - Issues related to biosimilars. - Issues related to drug shortages.

Medicare/Medicaid

Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.